Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
National Healthcare Properties, Inc.
Bear Case (25th pct.)
-56.1% vs price
Base Case (Median)
-45.7% vs price
Bull Case (75th pct.)
-45.0% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $13.70 | -45.7% | High (40%) |
| EV/EBITDA | $14.06 | -44.3% | Medium (20%) |
| EV/FCF | $8.45 | -66.5% | Medium (20%) |
Based on 3 out of 7 methods, NHPAP appears overvalued at the current price of $25.24. The base case fair value of $13.70 implies 45.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.